Join
Live feed
·
INSIDERFilingvia Quantisnow
TCR2 Therapeutics Inc. logo

SEC Form 4: Cardama Alfonso Quintas converted options into 95,385 shares and sold $5,054 worth of shares (3,636 units at $1.39) as part of a pre-agreed trading plan, increasing direct ownership by 196% to 138,664 units to satisfy withholding obligation

ByQuantisnow·Wall Street's wire, on your screen.
TCRR· TCR2 Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCRR (TCR2 Therapeutics Inc.) and more on Quantisnow.

SEC Form 4: Cardama Alfonso Quintas converted options into 95,385 shares and sold $5,054 worth of shares (3,636 units at $1.39) as part of a pre-agreed trading plan, increasing direct ownership by 196% to 138,664 units to satisfy withholding obligation | Quantisnow